Pharmac has widened access to two blood cancer medicines, but a leading clinician has questioned the decision's merits, given the availability of newer options.
Clinician questions Pharmac's decision to fund old cancer medicines over newer options
July 3, 2024 Latest NewsBioPharma![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/4ff153b152937b3bd06b28785e1aa5a8.png)
Latest Video
New Stories
-
Committee recommends major overhaul of diabetes management and access
July 5, 2024 - - Latest News -
New report reveals strong growth in valuations of local life science companies
July 5, 2024 - - Latest News -
Merck’s record support for the Australian Multiple Sclerosis Community
July 5, 2024 - - Latest News -
CSL's gene therapy becomes the first funded via the UK's 'Innovative Medicines Fund'
July 5, 2024 - - Latest News -
New Zealand pharmacies to administer more childhood vaccinations
July 4, 2024 - - Latest News -
Patients gather in Canberra to call for access ahead of next week's PBAC meeting
July 4, 2024 - - Latest News -
Medicines Australia wants changes made to draft immunisation strategy
July 3, 2024 - - Latest News